Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,555 | 7 | 46.9% |
| Honoraria | $4,600 | 3 | 25.2% |
| Food and Beverage | $4,316 | 254 | 23.7% |
| Education | $414.32 | 6 | 2.3% |
| Travel and Lodging | $348.06 | 8 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14,579 | 35 | $0 (2024) |
| Janssen Biotech, Inc. | $963.85 | 53 | $0 (2024) |
| Dermavant Sciences, Inc. | $609.58 | 56 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $387.49 | 50 | $0 (2024) |
| ABBVIE INC. | $387.27 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $266.08 | 9 | $0 (2024) |
| GENZYME CORPORATION | $205.90 | 6 | $0 (2024) |
| EPI Health, LLC | $150.99 | 5 | $0 (2022) |
| Lilly USA, LLC | $118.74 | 7 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $101.70 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,574 | 85 | Dermavant Sciences, Inc. ($358.13) |
| 2023 | $7,378 | 121 | Sun Pharmaceutical Industries Inc. ($6,375) |
| 2022 | $4,246 | 59 | Sun Pharmaceutical Industries Inc. ($3,182) |
| 2021 | $5,034 | 13 | SUN PHARMACEUTICAL INDUSTRIES INC. ($4,901) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $85.66 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $143.89 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: DERMATOLOGY | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.02 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.67 | General |
| 09/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: DERMATOLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,838 | 6,824 | $995,359 | $297,506 |
| 2022 | 17 | 3,757 | 7,806 | $737,910 | $308,470 |
| 2021 | 18 | 3,814 | 7,886 | $689,741 | $300,414 |
| 2020 | 17 | 3,385 | 6,654 | $622,258 | $244,327 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 762 | 960 | $183,930 | $56,476 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 447 | 573 | $151,357 | $46,252 | 30.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 532 | 604 | $132,848 | $41,552 | 31.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 109 | 139 | $93,182 | $31,268 | 33.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 531 | 680 | $99,388 | $25,966 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 224 | 224 | $52,643 | $15,744 | 29.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 111 | 133 | $49,641 | $15,616 | 31.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 419 | 2,686 | $40,290 | $12,807 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $40,997 | $12,791 | 31.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 102 | 108 | $27,413 | $8,834 | 32.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 150 | 226 | $24,743 | $8,155 | 33.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 67 | 83 | $44,984 | $7,702 | 17.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 138 | 158 | $13,503 | $5,652 | 41.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 32 | 36 | $22,064 | $3,694 | 16.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 59 | 59 | $9,009 | $2,549 | 28.3% |
| 69100 | Biopsy of ear | Office | 2023 | 30 | 30 | $6,354 | $1,559 | 24.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $3,014 | $888.89 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 652 | 976 | $179,180 | $80,832 | 45.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 475 | 564 | $85,914 | $40,661 | 47.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 619 | 844 | $101,280 | $34,448 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 446 | 559 | $71,980 | $32,878 | 45.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 110 | 141 | $62,604 | $24,845 | 39.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 481 | 3,597 | $53,955 | $17,653 | 32.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 207 | 207 | $35,190 | $14,082 | 40.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 264 | 319 | $26,900 | $11,641 | 43.3% |
About Mark Mazak, PA-C
Mark Mazak, PA-C is a Physician Assistant healthcare provider based in Lakewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285748897.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Mazak, PA-C has received a total of $18,233 in payments from pharmaceutical and medical device companies, with $1,574 received in 2024. These payments were reported across 278 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,555).
As a Medicare-enrolled provider, Mazak has provided services to 14,794 Medicare beneficiaries, totaling 29,170 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Lakewood, NJ
- Active Since 08/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1285748897
Products in Payments
- ILUMYA (Biological) $9,463
- Ilumya (Biological) $4,901
- VTAMA (Drug) $609.58
- REMICADE (Biological) $524.77
- TREMFYA (Drug) $439.08
- DUPIXENT (Biological) $304.03
- RINVOQ (Biological) $252.02
- Zoryve (Drug) $235.29
- Sotyktu (Drug) $232.34
- CLODERM (Drug) $150.99
- SKYRIZI (Biological) $109.19
- OLUMIANT (Drug) $83.03
- ADBRY (Biological) $79.76
- ZILXI (Drug) $53.00
- OPZELURA (Drug) $50.16
- Winlevi (Drug) $49.88
- TALTZ (Drug) $35.71
- COSENTYX (Drug) $24.42
- COSENTYX (Biological) $21.18
- Otezla (Drug) $16.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lakewood
Ms. Rachel Printy, Pa-C, PA-C
Physician Assistant — Payments: $24,573
Lyndsey O'rourke
Physician Assistant — Payments: $12,166
Joshua Cross
Physician Assistant — Payments: $8,523
Jessica Donahue, Pa-C, PA-C
Physician Assistant — Payments: $7,378
Lauren Mullins
Physician Assistant — Payments: $6,527
Alicia Snow, Pa-C, PA-C
Physician Assistant — Payments: $4,646